Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-23T03:42:18.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Necrotising otitis externa – is a poor outcome predictable? The application of a diagnosis-based scoring system in patients with skull base osteomyelitis

Published online by Cambridge University Press:  29 November 2021

D M Rojoa ,
F J Raheman ,
Y Saman ,
B Mettias ,
S Das  and
P A Rea
D M Rojoa*
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
F J Raheman
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Y Saman
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
B Mettias
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
S Das
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
P A Rea
Affiliation:
Department of Otolaryngology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK Balance Medicine, De Montfort University, Leicester, UK Department of Neuroscience and Informatics, University of Leicester, UK
*
Author for correspondence: Dr Djamila M Rojoa, Department of Otolaryngology, Leicester Royal Infirmary, LeicesterLE1 5WW, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The increased incidence of necrotising otitis externa over the last decade has had a significant burden on healthcare providers. Several factors may affect outcome, and stratifying risk may allow personalised treatment.

Method

Retrospectively identified patients were prospectively surveyed over 12 months. The Cox proportional hazards model was used to identify predictors of poor prognosis.

Results

Twenty-six patients with necrotising otitis externa (average age of 80 years) were admitted from 2018 to 2019. At one year, 19 per cent mortality was observed. A high Charlson Comorbidity Index was associated with increased mortality (p = 0.03), prolonged in-patient stay (p = 0.047) and increased odds of adverse outcomes (odds ratio = 1.48, 95 per cent confidence interval = 0.26–2.67, p = 0.019). The Charlson Comorbidity Index in our prognostic model was validated using the receiver operating characteristic curve (area under the curve = 0.76). Charlson Comorbidity Index score of 5 or more independently predicted one-year morbidity and mortality (hazard ratio = 1.30, 95 per cent confidence interval = 0.94–1.79, p = 0.03).

Conclusion

Risk-stratifying patients may enable clinicians to holistically counsel patients and tailor their treatment to improve their prognosis and subsequently alleviate the burden of necrotising otitis externa.

Keywords

Otitis ExternaSkull BaseOsteomyelitisComorbidityRisk AssessmentPrognosis
Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 136 , Issue 5 , May 2022 , pp. 379 - 385
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr D Rojoa takes responsibility for the integrity of the content of the paper

References

Mahdyoun, P, Pulcini, C, Gahide, I, Raffaelli, C, Savoldelli, C, Castillo, L et al. Necrotizing otitis externa: a systematic review. Otol Neurotol 2013;34:620–9CrossRefGoogle ScholarPubMed
Lucente, FE, Parisier, SC. James R. Chandler: ‘malignant external otitis.’. Laryngoscope 1996;106:805–7Google ScholarPubMed
Digital, NHS. Hospital admitted patient care activity. In: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity [10 August 2020]Google Scholar
Lee, SK, Lee, SA, Seon, SW, Jung, JH, Lee, JD, Choi, JY et al. Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol 2017;10:228–35CrossRefGoogle ScholarPubMed
Hollis, S, Evans, K. Management of malignant (necrotising) otitis externa. J Laryngol Otol 2011;125:1212–17CrossRefGoogle ScholarPubMed
Göllnitz, I, Inhestern, J, Wendt, TG, Buentzel, J, Esser, D, Böger, D et al. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany. Cancer Med 2016;5:3260–71CrossRefGoogle ScholarPubMed
Schwam, ZG, Ferrandino, R, Kaul, VZ, Wanna, GB, Cosetti, MK. Thirty-day readmission and prolonged length of stay in malignant otitis externa. Laryngoscope 2020;130:2220–8CrossRefGoogle ScholarPubMed
Kallogjeri, D, Gaynor, SM, Piccirillo, ML, Jean, RA, Spitznagel, EL, Piccirillo, JF. Comparison of comorbidity collection methods. J Am Coll Surg 2014;219:245–55CrossRefGoogle ScholarPubMed
Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83CrossRefGoogle ScholarPubMed
Ou, H-T, Mukherjee, B, Erickson, SR, Piette, JD, Bagozzi, RP, Balkrishnan, R. Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among Medicaid enrollees with type 2 diabetes. Popul Health Manag 2012;15:220–9CrossRefGoogle ScholarPubMed
Eveleigh, MO, Hall, CEJ, Baldwin, DL. Prognostic scoring in necrotising otitis externa. J Laryngol Otol 2009;123:1097–102CrossRefGoogle ScholarPubMed
Chen, C-N, Chen, Y-S, Yeh, T-H, Hsu, C-J, Tseng, F-Y. Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol 2010;130:89–94CrossRefGoogle ScholarPubMed
Kwon, BJ, Han, MH, Oh, SH, Song, JJ, Chang, K-H. MRI findings and spreading patterns of necrotizing external otitis: is a poor outcome predictable? Clin Radiol 2006;61:495–504CrossRefGoogle ScholarPubMed